Mayo clinic launches rare disease registry to unlock mysteries of calcium disorder
NCT ID NCT03478761
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is building a registry of up to 600 people with or suspected of having 24-hydroxylase deficiency, a rare genetic condition that causes high calcium levels and related problems like kidney stones. Researchers will collect health information over time to better understand the disease and its progression. The goal is to improve diagnosis and eventually develop new treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this registry could help doctors better understand this rare disease and point toward new treatments.
- What could go wrong
- This is an observational registry, not a treatment trial. It may take years to gather enough data, and there is no guarantee it will lead to new therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for 24-HYDROXYLASE DEFICIENCY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic
RECRUITINGRochester, Minnesota, 55905, United States